JPRN-UMIN000038397招募中未知
An open-label single-arm study on efficacy and safety of dopamine replacement therapy for drug-induced parkinsonism - An open-label single-arm study on efficacy and safety of dopamine replacement therapy for drug-induced parkinsonism
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Orthopedic conditions which preclude quantitative neurological assessments, such as fractures and severe arthralgia. 2. Severe intellectual disabilities which preclude accurate neurological assessments. 3. History of alcohol or other substance abuse. 4. Patients who are already diagnosed as having organic neurological diseases, or whose CT/MRI scans demonstrate cerebrovascular diseases (excluding a few to several numbers of small infarcts or microbleeds) or severe brain atrophy. 5. Patients who take levodopa or dopamine receptor agonists at the baseline assessment.
研究者
相似试验
尚未招募
2 期
A single arm, open-label study of Exportin 1 inhibitor selinexor in relapsed/refractory central nervous system (CNS) Lymphoma and in relapsed/refractory CNS MyelomaCentral nervous system diffuse large B cell lymphomaCentral nervous system myelomaCancer - MyelomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12621001361897Australasian Myeloma Research Consortium20
已完成
不适用
Clinical study to evaluate the safety and efficacy of a cream in reducing skin pigmentation in healthy pregnant females and lactating females with Mild to Moderate Melasma.CTRI/2022/08/044646Zydus Wellness Ltd50
已完成
不适用
Single arm open-label study to evaluate efficacy and safety of low intensity extracorporeal shockwave therapy in prostate cancer patients with ED after radical prostatectomyErectile dysfunctionJPRN-UMIN000022514Hiroshima University50
进行中（未招募）
不适用
A single arm, open label study to assess the efficacy, safety and tolerability of once- monthly administration of intravenous C.E.R.A. for the maintenance of haemoglobin levels in dyalysis patients with chronic renal anaemia - N/AEUCTR2006-006349-15-GRRoche (HELLAS) SA
进行中（未招募）
1 期
A single arm, open label study to assess the efficacy, safety, and tolerability of monthly administration of RO0503821 for the treatment of chronic renal anaemia in patients not on dialysis and not currently treated with ESA.EUCTR2006-006707-36-FIRoche Oy200